ReviewDiagnostics (Basel, Switzerland)2025
A Review of the Use of Data Analytics to Address Preeclampsia in Ecuador Between 2020 and 2024.
Review in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Preeclampsia is one of the leading causes of maternal and perinatal morbidity and mortality worldwide. The incidence of preeclampsia in Ecuador is approximately 51 cases per 1000 pregnancies. Despite advances in medicine, its diagnosis and management remain a challenge due to its multifactorial nature and variability in its clinical presentation. Data analytics offers an innovative approach to address these challenges, allowing for better understanding of the disease and more informed decision-making. This work review examines peer-reviewed studies published during the last decade that employed descriptive, diagnostic, predictive, and prescriptive analytics to evaluate preeclampsia in Ecuador. The review focuses on studies conducted in healthcare institutions across coastal and highland regions, with an inclusion criterion requiring sample sizes greater than 100 patients. Emphasis is placed on the statistical methods used, main findings, and the technological capabilities of the facilities where the analyses were performed. Critical evaluation of methodology limitations and a comparative discussion of findings with global literature on preeclampsia are included. The synthesis of these studies highlights both progress and gaps in predictive analytics for preeclampsia and suggests pathways for future research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.